De Marco C - Search Results

1

Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents.

Folini M, De Marco C, Orlandi L, Daidone MG, Zaffaroni N. Folini M, et al. Among authors: de marco c. Eur J Cancer. 2000 Oct;36(16):2137-45. doi: 10.1016/s0959-8049(00)00295-1. Eur J Cancer. 2000. PMID: 11044653

2

Activity of a chartreusin analog, elsamicin A, on breast cancer cells.

Silvestrini R, Sanfilippo O, Zaffaroni N, De Marco C, Catania S. Silvestrini R, et al. Among authors: de marco c. Anticancer Drugs. 1992 Dec;3(6):677-81. doi: 10.1097/00001813-199212000-00018. Anticancer Drugs. 1992. PMID: 1288737

3

Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.

Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R. Sanfilippo O, et al. Among authors: de marco c. Eur J Cancer. 1991;27(2):155-8. doi: 10.1016/0277-5379(91)90476-t. Eur J Cancer. 1991. PMID: 1673852

4

Purine salvage enzyme activities in normal and neoplastic human tissues.

Camici M, Tozzi MG, Allegrini S, Del Corso A, Sanfilippo O, Daidone MG, De Marco C, Ipata PL. Camici M, et al. Among authors: de marco c. Cancer Biochem Biophys. 1990 Jul;11(3):201-9. Cancer Biochem Biophys. 1990. PMID: 2125239

5

Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.

Zaffaroni N, Silvestrini R, Grignolio E, Villa R, DeMarco C. Zaffaroni N, et al. Int J Cell Cloning. 1988 Nov;6(6):392-403. doi: 10.1002/stem.5530060604. Int J Cell Cloning. 1988. PMID: 2466088 Free article.

6

Fludarabine as a modulator of cisplatin activity in human tumour primary cultures and established cell lines.

Zaffaroni N, Orlandi L, Gornati D, De Marco C, Vaglini M, Silvestrini R. Zaffaroni N, et al. Among authors: de marco c. Eur J Cancer. 1996 Sep;32A(10):1766-73. doi: 10.1016/0959-8049(96)00176-1. Eur J Cancer. 1996. PMID: 8983288

7

Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells.

Silvestrini R, Gornati D, Zaffaroni N, Bearzatto A, De Marco C. Silvestrini R, et al. Among authors: de marco c. Breast Cancer Res Treat. 1997 Jan;42(2):103-12. doi: 10.1023/a:1005725203159. Breast Cancer Res Treat. 1997. PMID: 9138599

8

Modulation of melphalan and cisplatin cytotoxicity in human ovarian cancer cells resistant to alkylating drugs.

Gornati D, Zaffaroni N, Villa R, De Marco C, Silvestrini R. Gornati D, et al. Among authors: de marco c. Anticancer Drugs. 1997 Jun;8(5):509-16. doi: 10.1097/00001813-199706000-00014. Anticancer Drugs. 1997. PMID: 9215615

9

Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis.

Orlandi L, Zaffaroni N, Bearzatto A, Villa R, De Marco C, Silvestrini R. Orlandi L, et al. Among authors: de marco c. Int J Cancer. 1998 Oct 29;78(3):377-84. doi: 10.1002/(SICI)1097-0215(19981029)78:3<377::AID-IJC20>3.0.CO;2-2. Int J Cancer. 1998. PMID: 9766575

10

Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.

Orlandi L, Bearzatto A, Abolafio G, De Marco C, Daidone MG, Zaffaroni N. Orlandi L, et al. Among authors: de marco c. Br J Cancer. 1999 Sep;81(2):252-60. doi: 10.1038/sj.bjc.6690685. Br J Cancer. 1999. PMID: 10496350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters